 | • レポートコード：TPM-B05036 • 出版社/出版日：Transparency Market Research / 2018年4月24日 • レポート形態：英文、PDF、188ページ • 納品方法：Eメール • 産業分類：Healthcare |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、動物用ワクチンの世界市場について調べ、動物用ワクチンの世界規模、市場動向、市場環境、動物の種類別（コンパニオンアニマル、家畜）分析、技術タイプ別（不活化ワクチン、弱毒生ワクチン、結合体ワクチン、トキソイドワクチン）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・動物用ワクチンの世界市場動向 ・動物用ワクチンの世界市場環境 ・動物用ワクチンの世界市場規模 ・動物用ワクチンの世界市場規模：動物の種類別（コンパニオンアニマル、家畜） ・動物用ワクチンの世界市場規模：技術タイプ別（不活化ワクチン、弱毒生ワクチン、結合体ワクチン、トキソイドワクチン） ・動物用ワクチンの世界市場：地域別市場規模・分析 ・動物用ワクチンの北米市場規模・予測 ・動物用ワクチンのアメリカ市場規模・予測 ・動物用ワクチンの中南米市場規模・予測 ・動物用ワクチンのヨーロッパ市場規模・予測 ・動物用ワクチンのアジア市場規模・予測 ・動物用ワクチンの日本市場規模・予測 ・動物用ワクチンの中国市場規模・予測 ・動物用ワクチンの中東市場規模・予測 ・動物用ワクチンのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Veterinary Vaccines Market: Overview
Transparency Market Research’s new report on the global veterinary vaccines market provides detailed insights on the future growth scenario of the said market based on past performance and current scenario. The report offers an exclusive analysis of the global market and also presents insights on key regions and key segments under different category that have been covered in the executive summary section.
The report offers a summary of the global market including a synopsis that highlights the core trends that come to the fore in the market. It also discusses vital indicators such as drivers, challenges, and trends prevalent in the global veterinary vaccines market. The report aspires to serve as a useful guide providing figures related to volume, value, and the development rate of the market from a growth point of view. The report thoroughly looks into each segment and provides estimates based on historic and current values. The evaluation of the veterinary vaccines market presented in the report is in the light of market conditions, including value chain analysis of key technology and animal type under study.
Global Veterinary Vaccines Market: Research Methodology
The making of the report involved an elaborate primary and secondary research phase. The primary research phase involved reaching out to opinion leaders and industry experts via e-mail, face-to-face interviews, and telephonic interviews. Primary interviews were conducted with industry experts on an ongoing basis to endorse data and research analysis. The secondary research phase involved reaching out to accredited industry sources and gathering data.
Global Veterinary Vaccines Market: Competitive Dashboard
The report includes a detailed profile of the key companies currently operating in the veterinary vaccines market. The companies are profiled on the basis of key parameters such as company and financial overview, latest developments, product portfolio, and long-term and short-term growth strategies. The competition matrix covered in the report is likely to assist the existing players to boost their market shares and new entrants in the market to establish a foothold in the veterinary vaccines market.
The report also sheds light on government mandates and regulations pertaining to veterinary vaccines in different countries which is a highlight of the report. The report talks about the manufacturing and sales of veterinary vaccines along with the new research and key development initiatives underway in the global veterinary vaccines market.
Key companies in the veterinary vaccines market, namely Zoetis Inc., Bayer AG, Boehringer Ingelheim GmbH, Merck and Co., Bimeda Inc., Ceva Sante Animale, Sanofi S.A., and Eli Lily and company have been profiled in this report.
What does our report offer?
The report is the outcome of meticulous research work carried out by market analysts employing reliable industry-best analytical tools. The information collated has been validated by seasoned market researchers.
レポート目次Chapter 1 Preface
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Key Questions Answered
Chapter 2 Assumptions and Research Methodology
2.1 Report Assumptions
2.2 Acronyms Used
2.3 Research Methodology
Chapter 3 Executive Summary
3.1 Global Veterinary Vaccines Market Snapshot
3.2 Market Opportunity Map
Chapter 4 Market Overview
4.1 Product Overview
4.2 Key Industry Events
4.3 Disease Outbreak Globally: Livestock Animals Disease
4.4 Main (Vector Borne Disease) VBDs affecting livestock
4.5 List of countries representing each virus pool (FMD) for the period 2010–2014
4.6 Animal Population (Mn), by Country in 2015
4.7 Regulatory Scenario
Chapter 5 Market Dynamics
5.1 Drivers and Restraints Snapshot Analysis
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 White Space Analysis
Chapter 6 Veterinary Vaccines Market Analysis, by Technology Type, (US$ Mn) 2014–2024
6.1 Key Findings
6.2 Introduction
6.3 Inactivated Vaccines
6.4 Live Attenuated Vaccines
6.5 Conjugate Vaccines
6.6 Toxoid Vaccines
6.7 Recombinant Vaccines
6.8 DNA Vaccines
6.9 Key Trends
6.10 Veterinary Vaccines Market Attractiveness Analysis, by Technology Type, 2015
Chapter 7 Veterinary Vaccines Market Analysis, by Animal Type, (US$ Mn), 2014–2024
7.1 Key Findings
7.2 Introduction
7.3 Veterinary vaccines (companion animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
7.3.1 Equine
7.3.2 Canine
7.3.3 Feline
7.4 Veterinary vaccines (livestock animals) Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
7.4.1 Bovine
7.4.2 Ovine
7.4.3 Porcine
7.4.4 Poultry
7.5 Key Trends
7.6 Veterinary Vaccines Market Attractiveness Analysis, by Animal Type
Chapter 8 Veterinary Vaccines Market Analysis, by Region, (US$ Mn), 2014–2024
8.1 North America
8.2 Europe
8.3 Asia Pacific
8.4 Latin America
8.5 Middle East & Africa
8.6 Geographical Scenario
8.7 Veterinary Vaccines Market Attractiveness Analysis, by Region, 2015
Chapter 9 North America Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
9.1 North America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
9.1.1 Inactivated Vaccines
9.1.2 Conjugate Vaccines
9.1.3 Live Attenuated Vaccines
9.1.4 Toxoid Vaccines
9.1.5 Other Vaccines
9.2 North America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
9.2.1 Animal Type
9.2.1.1 Companion Animals
9.2.1.1.1 Equine
9.2.1.1.2 Canine
9.2.1.1.3 Feline
9.2.1.2 Livestock Animals
9.2.1.2.1 Bovine
9.2.1.2.2 Ovine
9.2.1.2.3 Porcine
9.2.1.2.4 Poultry
9.2.1.2.5 Others
9.3 U.S. Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
9.4 Canada Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
Chapter 10 Europe Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
10.1 Europe Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
10.1.1 Inactivated Vaccines
10.1.2 Conjugate Vaccines
10.1.3 Live Attenuated Vaccines
10.1.4 Toxoid Vaccines
10.1.5 Other Vaccines
10.2 Europe Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
10.2.1 Animal Type
10.2.1.1 Companion Animals
10.2.1.1.1 Equine
10.2.1.1.2 Canine
10.2.1.1.3 Feline
10.2.1.2 Livestock Animals
10.2.1.2.1 Bovine
10.2.1.2.2 Ovine
10.2.1.2.3 Porcine
10.2.1.2.4 Poultry
10.2.1.2.5 Others
10.3 Europe Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
10.4 Germany Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
10.5 U.K. Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
Chapter 11 Asia Pacific Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
11.1 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
11.1.1 Inactivated Vaccines
11.1.2 Conjugate Vaccines
11.1.3 Live Attenuated Vaccines
11.1.4 Toxoid Vaccines
11.1.5 Other Vaccines
11.2 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
11.2.1 Animal Type
11.2.1.1 Companion Animals
11.2.1.1.1 Equine
11.2.1.1.2 Canine
11.2.1.1.3 Feline
11.2.1.2 Livestock Animals
11.2.1.2.1 Bovine
11.2.1.2.2 Ovine
11.2.1.2.3 Porcine
11.2.1.2.4 Poultry
11.2.1.2.5 Others
11.3 Asia Pacific Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
11.4 China Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
11.5 Japan Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
Chapter 12 Latin America Veterinary vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
12.1 Latin America Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
12.1.1 Inactivated Vaccines
12.1.2 Conjugate Vaccines
12.1.3 Live Attenuated Vaccines
12.1.4 Toxoid Vaccines
12.1.5 Other Vaccines
12.2 Latin America Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
12.2.1 Animal Type
12.2.1.1 Companion Animals
12.2.1.1.1 Equine
12.2.1.1.2 Canine
12.2.1.1.3 Feline
12.2.1.2 Livestock Animals
12.2.1.2.1 Bovine
12.2.1.2.2 Ovine
12.2.1.2.3 Porcine
12.2.1.2.4 Poultry
12.2.1.2.5 Others
12.3 Latin America Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
12.4 Brazil Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
12.5 Mexico Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
Chapter 13 Middle East & Africa Veterinary Vaccines Market Revenue Analysis, (US$ Mn), 2014–2024
13.1 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Technology Type, (US$ Mn), 2014–2024
13.1.1 Inactivated Vaccines
13.1.2 Conjugate Vaccines
13.1.3 Live Attenuated Vaccines
13.1.4 Toxoid Vaccines
13.1.5 Other Vaccines
13.2 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Animal Type, (US$ Mn), 2014–2024
13.2.1 Animal Type
13.2.1.1 Companion Animals
13.2.1.1.1 Equine
13.2.1.1.2 Canine
13.2.1.1.3 Feline
13.2.1.2 Livestock Animals
13.2.1.2.1 Bovine
13.2.1.2.2 Ovine
13.2.1.2.3 Porcine
13.2.1.2.4 Poultry
13.2.1.2.5 Others
13.3 Middle East & Africa Veterinary Vaccines Market Value Share Analysis, by Country, (US$ Mn), 2014–2024
13.4 Saudi Arabia Veterinary Vaccines Market Analysis, (US$ Mn), 2014–2024
Chapter 14 Competitive Landscape
14.1 Veterinary Vaccine Market Share Analysis, by Company, (2015)
14.2 Competition Matrix
14.2.1 Bayer AG
14.2.2 Bimeda, Inc.
14.2.3 Boehringer Ingelheim GmbH
14.2.4 Ceva Santé Animale
14.2.5 Eli Lilly and Company (Elanco Animal Health)
14.2.6 Merck Animal Health
14.2.7 Sanofi S.A. (Merial Animal Health)
14.2.8 Virbac
14.2.9 Zoetis, Inc.
14.3 Company Profiles
14.3.1 Bayer AG
14.3.1.1 Company Details
14.3.1.2 Company Description
14.3.1.3 Business Overview
14.3.1.4 SWOT Analysis
14.3.1.5 Financials
14.3.1.6 Strategic Overview
14.3.1.7 Product Portfolio
14.3.1.8 Recent Developments
14.3.2 Bimeda, Inc.
14.3.2.1 Company Details
14.3.2.2 Company Description
14.3.2.3 Business Overview
14.3.2.4 SWOT Analysis
14.3.2.5 Financials
14.3.2.6 Strategic Overview
14.3.2.7 Product Portfolio
14.3.2.8 Recent Developments
14.3.3 Boehringer Ingelheim GmbH
14.3.3.1 Company Details
14.3.3.2 Company Description
14.3.3.3 Business Overview
14.3.3.4 SWOT Analysis
14.3.3.5 Financials
14.3.3.6 Strategic Overview
14.3.3.7 Product Portfolio
14.3.3.8 Recent Developments
14.3.4 Ceva Santé Animale
14.3.4.1 Company Details
14.3.4.2 Company Description
14.3.4.3 Business Overview
14.3.4.4 SWOT Analysis
14.3.4.5 Financials
14.3.4.6 Strategic Overview
14.3.4.7 Product Portfolio
14.3.4.8 Recent Developments
14.3.5 Eli Lilly and Company (Elanco Animal Health)
14.3.5.1 Company Details
14.3.5.2 Company Description
14.3.5.3 Business Overview
14.3.5.4 SWOT Analysis
14.3.5.5 Financials
14.3.5.6 Strategic Overview
14.3.5.7 Product Portfolio
14.3.5.8 Recent Developments
14.3.6 Merck Animal Health
14.3.6.1 Company Details
14.3.6.2 Company Description
14.3.6.3 Business Overview
14.3.6.4 SWOT Analysis
14.3.6.5 Financials
14.3.6.6 Strategic Overview
14.3.6.7 Product Portfolio
14.3.6.8 Recent Developments
14.3.7 Sanofi S.A. (Merial Animal Health)
14.3.7.1 Company Details
14.3.7.2 Company Description
14.3.7.3 Business Overview
14.3.7.4 SWOT Analysis
14.3.7.5 Financials
14.3.7.6 Strategic Overview
14.3.7.7 Product Portfolio
14.3.7.8 Recent Developments
14.3.8 Virbac
14.3.8.1 Company Details
14.3.8.2 Company Description
14.3.8.3 Business Overview
14.3.8.4 SWOT Analysis
14.3.8.5 Financials
14.3.8.6 Strategic Overview
14.3.8.7 Product Portfolio
14.3.8.8 Recent Developments
14.3.9 Zoetis, Inc.
14.3.9.1 Company Details
14.3.9.2 Company Description
14.3.9.3 Business Overview
14.3.9.4 SWOT Analysis
14.3.9.5 Financials
14.3.9.6 Strategic Overview
14.3.9.7 Product Portfolio
14.3.9.8 Recent Developments
Table 1. Global Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 2. Global Veterinary Vaccines (companion animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 3. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 4. Global Veterinary Vaccines Market Size Forecast, by Region, (US$ Mn), 2014–2024
Table 5. North America Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 6. Global Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 7. Global Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 8. North America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 9. Europe Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 10. Europe Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 11. Europe Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 12. Europe Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 13. Asia Pacific Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 14. Asia Pacific Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 15. Asia Pacific Veterinary Vaccines (livestock animals) Market Size Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 16. Asia Pacific Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 17. Latin America Veterinary Vaccines Market Size (US$ Mn) Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 18. Latin America Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 19. Latin America Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 20. Latin America Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024
Table 21. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Technology Type, (US$ Mn), 2014–2024
Table 22. Middle East & Africa Veterinary Vaccines (companion animals) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 23. Middle East & Africa Veterinary Vaccines (livestock animals) Market Size (US$ Mn) Forecast, by Animal Type, (US$ Mn), 2014–2024
Table 24. Middle East & Africa Veterinary Vaccines Market Size Forecast, by Country, (US$ Mn), 2014–2024